Impact on quality of life from multi-modality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multi-modality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial)
Authors
Taylor, SallyTsim, S
Navani, N
Baldwin, D
Woolhouse, I
Edwards, J
Grundy, S
Robson, J
Rhodes, S
Burnside, N
Blackhall, Fiona H
Faivre-Finn, Corinne
Yorke, Janelle
Evison, M
Affiliation
Christie Patient Centred Research, The Christie NHS Foundation Trust, Manchester, UKIssue Date
2021-07
Metadata
Show full item recordCitation
Taylor, Sally, Tsim, S ,Navani, N, Baldwin, D, Woolhouse, I, Edwards, J, Grundy, S, Robson, J, Rhodes, S Burnside, N, Blackhall, Fiona H,Faivre-Finn, Corinne, Yorke, Janelle, Evison, M. Impact on quality of life from multi-modality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multi-modality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial) Lung Cancer. 2022 Jul; 8(1): e000846.Journal
Lung CancerDOI
10.1136/bmjresp-2020-000846PubMed ID
34266853Additional Links
https://dx.doi.org/10.1136/bmjresp-2020-000846Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1136/bmjresp-2020-000846